Current clinical trials - Mater Research

Neuroscience

The Neuroscience Clinical Trials Team conducts clinical trials for patients with dementia, epilepsy, migraine and headache disorders, stroke, movement disorders and other neurological conditions.

Maplight - An experimental drug to moderate behavioural symptoms in people with autism

A clinical trial to investigate the efficacy, safety and tolerability of ML-004 for treatment of the core behavioural symptoms in Autistic people.

Trial status: Recruiting

Contact: Delphine Lévy-Bencheton

RESOLUTION – Preventative treatment for migraine in patients with medication overuse headaches

Evaluating eptinezumab with a brief educational intervention for prevention of migraine in patients with migraine and medication overuse headache.

Trial status: Active, not recruiting

Contact: Stevie Anderson

UMPIRE - Trial of an implantable device for continuous monitoring of epileptic seizure activity.

A clinical trial to assess the safety of an experimental device implanted under the scalp for continuous recording of brain electrical activity associated the epileptic seizures.

Trial status: Active, not recruiting

Contact: Delphine Lévy-Bencheton

X-ACKT: Clinical trial of a new drug for generalised epilepsy

This study is trialing a novel anti-epileptic medication called XEN1101 in patients who suffer from primary generalized tonic-clonic seizures and have not achieved satisfactory seizure control using standard therapies.

Trial status: Recruiting

Contact: Delphine Lévy-Bencheton

X-TOLE2: Clinical trial of a new drug for focal epilepsy

This study is trialing a novel anti-epileptic medication called XEN1101 in focal epilepsy patients who have not achieved satisfactory seizure control on at least two anti-epileptic medications.

Trial status: Recruiting

Contact: Delphine Lévy-Bencheton

Search whole site

Clinical trials categories